Lam Research Corp. 10-Q Summary: Quarter Ended September 30, 1998
Business Context and Reporting Period
This Form 10-Q covers the first quarter of fiscal year 1999, ended September 30, 1998. Lam Research Corporation is a manufacturer of semiconductor manufacturing equipment, primarily focusing on etch and Chemical Mechanical Planarization (CMP) systems. The company is currently navigating a severe worldwide slowdown in the semiconductor industry, characterized by depressed DRAM pricing and production overcapacity. The company is in the midst of a significant restructuring to exit Flat Panel Display (FPD) and Chemical Vapor Deposition (CVD) operations.
Key Financial Metrics
| Metric | Q1 FY1999 (Sep 30, 1998) | Q1 FY1998 (Sep 30, 1997) |
|---|---|---|
| Net Sales | $142.1 million | $289.4 million |
| Total Revenue | $142.2 million | $289.9 million |
| Gross Margin | 35.3% | 39.0% |
| Operating Loss | $(26.8) million | $(12.1) million |
| Net Loss | $(26.8) million | $(12.2) million |
| Net Loss Per Share (Basic/Diluted) | $(0.70) | $(0.32) |
| Cash and Cash Equivalents | $129.8 million | $13.5 million (Jun 30, 1998) |
| Short-term Investments | $210.0 million | $383.6 million (Jun 30, 1998) |
| Total Debt (Current + Long-term) | $348.5 million | $351.5 million (Jun 30, 1998) |
| Operating Cash Flow | $(49.4) million | $19.0 million |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 51% year-over-year due to a severe industry-wide slowdown. International sales dropped to 42% of total revenue from 51% in the prior year, with significant declines in Asia Pacific (15% vs. 31%) and Japan (6% vs. 9%).
- Margin Compression: Gross margin percentage fell to 35.3% from 39.0%, primarily driven by excess manufacturing capacity relative to lower sales volume.
- Expense Reductions: R&D expenses decreased 35.2% and SG&A expenses decreased 21.4% compared to the prior year, reflecting the ongoing restructuring and exit from non-core product lines (FPD and CVD).
- Restructuring Costs: While the major $148.9 million restructuring charge was recorded in prior quarters, the company made approximately $17 million in cash payments during this quarter. A remaining accrual of $30.2 million exists on the balance sheet.
- Liquidity Shift: Cash and cash equivalents increased significantly to $129.8 million from $13.5 million at the end of the prior quarter, driven by the net sale of short-term investments ($170 million net cash provided by investing activities).
Guidance, Outlook, and Risks
- Outlook: Management anticipates net sales will decrease for the remainder of calendar 1998 compared to the quarter ended September 30, 1998. Royalty income is expected to remain relatively flat.
- Future Restructuring: The company commenced a workforce reduction in November 1998 and plans to consolidate facilities. A new restructuring charge is expected to be recorded in the fiscal quarter ending December 1998, though costs are not yet quantified.
- Product Launch: The company anticipates shipping its Teres CMP system in fiscal 1999, which will face significant competition.
- Risk Factors:
- Industry Volatility: Continued severe slowdown in semiconductor equipment demand and extreme pricing volatility.
- International Exposure: Currency devaluation in Korea and Japan, and credit difficulties for customers in Asia, are curtailing orders.
- Year 2000 Compliance: The company is incurring costs to ensure internal and customer product compliance, though management does not expect a material adverse financial impact.
- Legal Proceedings: Ongoing patent infringement litigation with Varian Associates; management believes this will not have a material adverse effect.
Investor Verification Checklist
- Verify the magnitude and timing of the anticipated restructuring charge for the quarter ending December 1998.
- Monitor the progress of the Teres CMP system launch and market acceptance against competitors.
- Assess the impact of Asian currency devaluation and credit constraints on future order bookings.
- Review the company's cash burn rate given the negative operating cash flow of $49.4 million, despite strong investment liquidation.
- Confirm the status of the Varian patent litigation and any potential settlement costs.